1. mTOR Inhibitors in Advanced Biliary Tract Cancers
   Chao-En Wu et al, 2019, International Journal of Molecular Sciences CrossRef
2. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy
   Elisabetta Ninfole et al, 2021, World Journal of Clinical Cases CrossRef
3. Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models
   Qingfan Zheng et al, 2022, Frontiers in Oncology CrossRef
4. Paracrine Interaction of Cholangiocellular Carcinoma with Cancer-Associated Fibroblasts and Schwann Cells Impact Cell Migration
   Jan-Paul Gundlach et al, 2022, Journal of Clinical Medicine CrossRef
5. Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
   Hanjiao Qin et al, 2023, Frontiers in Pharmacology CrossRef
6. Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
   Kishor Pant et al, 2020, Frontiers in Medicine CrossRef
7. Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption
   Jingyao Wei et al, 2021, Frontiers in Pharmacology CrossRef
8. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
   null Chen et al, 2019, Cells CrossRef
9. Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
   Katharina Joechle et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
10. The AKT/mTOR Signaling Pathway Was Mediated through the LINC00514/miR-28-5p/TRIM44 Axis
    Lin Wu et al, 2022, Disease Markers CrossRef
11. The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
    Jun Wu et al, 2021, Frontiers in Oncology CrossRef
12. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro
    Hui Xie et al, 2022, Cancers CrossRef